Automated Cell Counter Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Automated Cell Counter Market Through 2025?
The market for automated cell counters has seen robust growth recently. It is forecasted to expand from $5.42 billion in 2024 to $5.79 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The previous growth in this market can be credited to heightened awareness, advancements in diagnostic methods, environmental influencers, the growth of antifungal resistance, population increase, and the higher number of individuals with compromised immunity.

What's the Projected Size of the Global Automated Cell Counter Market by 2029?
Anticipated to exhibit robust growth in the upcoming years, the market for automated cell counters is projected to expand to $7.48 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. This growth over the forecast period can be ascribed to a variety of factors such as regulatory backing, ecological issues, antimicrobial resistance, an older population demographic, advances in precision medicine, worldwide health care expenditure, occurrences of infectious disease, funding for research, access and affordability. The forecast period will be marked by notable shifts including regulatory encouragement for innovation, the growth of the biopharmaceutical field, a surge in research affairs, international development in health care infrastructure, a transition towards remote monitoring and an increase in point-of-care testing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/automated-cell-counter-global-market-report

Top Growth Drivers in the Automated Cell Counter Industry: What's Accelerating the Market?
The trend of adopting personalized medicine is projected to fuel the expansion of the automated cell counter market in the future. Personalized medicine involves adapting medical care to match each patient's specific traits, which often include genetic, environmental, and lifestyle influences. As a result of advancements in genetic studies and technology, the use of personalized medicine is becoming more prevalent, permitting the application of more targeted and efficient treatments suited to each patient's distinct genetic make-up and health information. Automated cell counting is a key tool in personalized medicine, enabling the prompt and precise analysis of cell populations specific to each patient, thus contributing to the development of treatment plans based on individual cellular characteristics. For instance, the Personalized Medicine Coalition (PMC), a hospital and healthcare company in the US, stated in February 2024 that the FDA had given authorization for 16 new treatments for patients with rare diseases, a substantial rise from the 6 approved in 2022. Consequently, the increased usage of personalized medicine will stimulate the expansion of the automated cell counter market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15730&type=smp

What Trends Will Shape the Automated Cell Counter Market Through 2029 and Beyond?
Prime corporations in the automated cell counter market are concentrating on incorporating smart algorithms and machine learning capabilities, such as the AI automated cell culture system. This technology aims to streamline and automate cell growth and scalability procedures in biological studies and biomanufacturing. An AI-automated cell culture system employs artificial intelligence to independently oversee, regulate, and enhance cell growth and maintenance in lab environments. For example, in October 2023, Molecular Devices LLC, an American provider of analytical systems, launched CellXpress.ai, an automated cell culture system. This comprehensive, machine learning integrated solution automates intense feeding and passaging schedules via an all-in-one incubator, liquid handler, and imager, thereby providing scientists with more freedom and time in the lab. This central hub features state-of-the-art technology specifically aimed at smoothly managing the whole cell journey. It is equipped with advanced machine learning based software that makes navigating and managing intricate cell culture processes easier, and comes with pre-set protocols for creating both 2D and 3D models.

What Are the Main Segments in the Automated Cell Counter Market?
The automated cell counter market covered in this report is segmented -

1) By Product: Consumable Accessories, Instruments
2) By Application: Blood Analysis, Urine Analysis, Microbial Cell Count, Cell Line Viability, Other Applications
3) By End User: Pharmaceuticals And Biotechnology Companies, Hospitals, Diagnostics Laboratories, Research Institutes, Other End-Users

Subsegments:
1) By Consumable Accessories: Cell Counting Reagents, Cell Counting Slides, Sample Tubes
2) By Instruments: Hemocytometers, Flow Cytometers, Automated Cell Counters (Optical Or Impedance-Based)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15730&type=smp

Which Top Companies are Driving Growth in the Automated Cell Counter Market?
Major companies operating in the automated cell counter market are Thermo Fisher Scientific Inc., Abbott Laboratories, F.Hoffmann-La Roche Ltd., Danaher Corporation, Merck KGaA, BD Biosciences, GE HealthCare Technologies Inc., Corning Incorporated, Agilent Technologies Inc., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad laboratories Inc., HORIBA Ltd., Eppendorf, Tecan Group, Miltenyi Biotec, Luminex Corporation, Molecular Devices LLC, Chemometec A/S, NanoEnTek Inc., Sony Biotechnology Inc., Countstar Inc., Aligned Genetics Inc.

Which Regions Will Dominate the Automated Cell Counter Market Through 2029?
North America was the largest region in the automated cell counter market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated cell counter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15730

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.